COSBI’s Post

Thank you Prof. Aidan Hollis for co-authoring this first publication towards my PhD - more to come in the near future!! :) Title: Pull me – push you? The disparate financing mechanisms of drug research in global health Abstract: "There is an inconsistency in the way pharmaceutical research is financed. While pull mechanisms are predominantly used to incentivize later-stage pharmaceutical research for products with demand in the Global North, so-called neglected diseases are chiefly financed by push funding. This discrepancy has so far been ignored in the academic debate, and any compelling explanation for why we draw the line between push and pull at poor people is lacking. Free access article in Globalization and Health here: https://lnkd.in/ep5zw3zi (... and for those not educated on the PushmePullyu: https://lnkd.in/eWR6jfjh)

🌟 CAPKR is at the FDA event this week🌟 Centre for Applied Pharmacokinetic Research (CAPKR) at The University of Manchester is yet again at the forefront of international efforts to modernize drug development with Prof. Amin Rostami-Hodjegan, Director of #CAPKR, leading a pivotal workshop at the FDA on May 2-3rd 2024. 🔬 The Workshop "Considerations and Potential Regulatory Applications for a Model Master File" will illuminate how Model Master Files (MMF) can significantly enhance the efficiency of modeling and simulation (M&S) in drug product development. Prof. Amin Rostami-Hodjegan will spearhead discussions on 📌 The potential benefits and incentives for stakeholders to develop and use an MMF for new drugs and generic locally acting drug products. 📌 Important considerations in the MMF lifecycle. This engagement highlights the strength of the ongoing collaboration of #CAPKR with the #FDA as the only UK higher education entity holding a Memorandum of Understanding (MOU) Agreement with the FDA. This highlights CAPKR’s unique path for knowledge exchange with the regulators within a formal collaborative framework that leads to real-world “impact” in pharmaceutical regulation and drug development. #FDA #UniversityOfManchester #CAPKR #DrugDevelopment #Pharmacokinetics #RegulatoryScience #CDER

Understanding ADME and clinical pharmacology is key to successful drug development, but regulatory complexities and inconsistent data handling can be challenging. Certara's Sr. Director of PBPK Consultancy, Shinji Yamazaki, PhD, will be attending the Pharmaceutical & Bioscience Society (PBSS) workshop, where he'll lead a talk on Transporter-Mediated Drug-Drug Interactions. Shinji will join industry experts to share key strategies and insights for navigating these challenges, helping you make informed decisions to drive successful IND/NDA filings. Learn more about this event here: https://lnkd.in/dyDm4cKm

Are you a biotech or pharmaceutical company working in cannabinoid R&D? The Cannabinoid Research & Development Group (CRDG) is hosting a series of investor briefings aimed at raising the profile of pharmaceutical cannabinoid R&D within the life-science investment community. These briefings lead up to our Cannabinoid Pharma & Biotech Investment Summit, a unique new gathering of biotech pharma companies, investors and cannabinoid researchers, to be held in spring next year. During the summit CRDG members will have the opportunity to showcase their innovations. As a member of CRDG, you will have a voice in shaping critical areas such as regulatory reforms, innovative clinical trial models and industry thought leadership. Membership also provides valuable networking opportunities with key stakeholders and potential collaborators. If your company is exploring the potential of cannabinoids and looking for funding opportunities, we invite you to discuss becoming a CRDG member. For more information on our work, and to sign up to our newsletter, visit CRDG.uk or contact steve@crdg.uk #CannabinoidResearch, #BiotechInnovation, #PharmaceuticalRD, #LifeSciences, #ClinicalTrials, #MedicalInnovation, #CannabinoidMedicine, #RegulatoryReform, #BiotechInvestment, #PharmaLeadership, #HealthTech

Session on "Breaking Boundaries with Innovations in Pharmaceutical"

How do you ensure that pharma campaigns are based on evidence rather than assumption? Through methodology, framework and structure. After a series of failed launches, a more involved approach will be required for drugs that treat Alzheimer’s, Parkinson’s and other neurodegenerative diseases. That’s where behavioural science comes in. You can read about how behavioural science has been used successfully in this article for the International Pharmaceutical Industry Journal by William H: https://lnkd.in/emfAKUSj

Pharmaceutical waste from a Danish hospital New study in Basic & Clinical Pharmacology & Toxicology aimed to characterize the quantity and composition of pharmaceutical waste from a major Danish hospital. It found large variations in the amount and composition of waste between departments, but some common patterns were identified. Considerable amounts of paracetamol and antibiotics were identified in the waste from several departments, while propofol alone accounted for about one third of the pharmaceutical waste from operating rooms. This suggests some key areas for improved management and reduction of pharmaceutical waste. Study conducted by Lærke Karner Overgaard, Katrine Bitsch Johansen, Julie Rudbech Krumborg, Michelle Lyndgaard Nielsen, Mette Marie Hougaard Christensen and Sidsel Arnspang Pedersen. Read the full paper here: https://lnkd.in/d45G3UXt

I'm thrilled to share our latest publication, "Truth in a Pill," now available in the International Journal of Basic & Clinical Pharmacology. Alongside my esteemed colleagues Dr. Shambo S. Samajdar, Dr. Shravan Venkatraman, Dr. Shashank Joshi, and Dr. Kaushik Biswas, we delve into the critical world of generic drugs, examining their development, regulatory challenges, and the vital role they play in healthcare. Our review provides insights into why generics are essential for broadening access to medicines and highlights the stringent processes involved in ensuring they meet safety and efficacy standards. This article is a must-read for healthcare professionals and anyone interested in the intricacies of pharmaceutical regulations. Shambo Samrat Samajdar Shashank Joshi Dr.Kaushik Biswas Check out the full article here for a deep dive into the fascinating world of generics: DOI: https://lnkd.in/dTPjB3JA

🌟 Excited to Announce My Latest Research Publication! 🌟 I'm proud to share that my review article, "Preparation and evaluation of transdermal gel using Naproxen," has been published in the International Journal of Science and Research Archive (IJSRA)! 📑 This achievement marks a significant step in my journey within pharmaceutical research and drug delivery systems. Working on this paper allowed me to dive deeper into innovative healthcare solutions, specifically exploring the potential of transdermal gel technology. 💊🔬 Key Highlights: Journal: International Journal of Science and Research Archive (IJSRA) Topic: Transdermal Gel Formulation using Naproxen Objective: Enhancing drug delivery systems for improved patient care A big thank you to my mentors, peers, and the editorial team at IJSRA for their guidance and support! Here’s to more discoveries and contributions to the field of pharmaceutical science and healthcare innovation. #PharmaceuticalResearch #DrugDelivery #TransdermalTechnology #HealthcareInnovation #ScientificPublication #IJSRA #LinkedInSEO #CareerGrowth

Register Now for the Fundamentals of Pharmacokinetics MasterClass - US Edition: https://lnkd.in/gSjVKUj2 Master how to learn and confirm the key characteristics of new molecular entities quantitatively. Join us for a comprehensive MasterClass on the Fundamentals of Pharmacokinetics, a cornerstone in drug development and therapy optimization. Delving deep into the foundational principles, methodologies, and applications of pharmacokinetics, attendees will gain an in-depth understanding that bridges both the science and its practical implementation. 🗓️ Dates: 06th - 09th February, 2024 🌍 Location: Virtual 🎓 Speaker: Stefano Persiani Don't miss out on this prime opportunity to enhance your expertise in the field of pharmacokinetics. Given the intricate nature of drug absorption, distribution, metabolism, and excretion, mastering these principles is imperative for professionals in the pharmaceutical domain. Availability is limited, so ensure you register soon! Dive deep into pharmacokinetics and be at the cutting edge of drug development and evaluation. #masterclass #glceurope #globalleadingconferences #pharmacokinetics #drugdevelopment #ProfessionalDevelopment